Basel Medical (BMGL) Invested Capital: 2023-2025
Historic Invested Capital for Basel Medical (BMGL) over the last 3 years, with Q2 2025 value amounting to $6.5 million.
- Basel Medical's Invested Capital fell 2564.71% to $6.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $6.5 million, marking a year-over-year decrease of 2564.71%. This contributed to the annual value of $6.5 million for FY2025, which is 2592.1% down from last year.
- According to the latest figures from Q2 2025, Basel Medical's Invested Capital is $6.5 million, which was down 2564.71% from $62277.0 recorded in Q4 2024.
- Basel Medical's Invested Capital's 5-year high stood at $8.8 million during Q2 2024, with a 5-year trough of $62277.0 in Q4 2024.
- Its 3-year average for Invested Capital is $3.8 million, with a median of $3.3 million in 2023.
- As far as peak fluctuations go, Basel Medical's Invested Capital plummeted by 91.87% in 2024, and later plummeted by 2564.71% in 2025.
- Quarter analysis of 3 years shows Basel Medical's Invested Capital stood at $62854.4 in 2023, then decreased by 0.92% to $62277.0 in 2024, then skyrocketed by 10358.28% to $6.5 million in 2025.
- Its Invested Capital was $6.5 million in Q2 2025, compared to $62277.0 in Q4 2024 and $8.8 million in Q2 2024.